Definitive findings from the Babybreathe Trial – Preventing return to smoking postpartum
Time: 11:45 am - 12:05 pm
Date: 5th March 2025
Most people who manage to quit smoking in pregnancy relapse postpartum. BabyBreatheTM is a complex intervention offering targeted one-to-one behavioural support in the community, delivered either face-to-face or remotely, alongside digital, and pharmacological support. In this presentation we report definitive outcomes from a randomised controlled trial (RCT) to compare the BabyBreatheTM intervention with usual care. 887 participants… Read more »
SCAH 2025Most people who manage to quit smoking in pregnancy relapse postpartum. BabyBreatheTM is a complex intervention offering targeted one-to-one behavioural support in the community, delivered either face-to-face or remotely, alongside digital, and pharmacological support. In this presentation we report definitive outcomes from a randomised controlled trial (RCT) to compare the BabyBreatheTM intervention with usual care. 887 participants were recruited to target and randomised. The primary outcome is 12-month sustained smoking abstinence, verified by exhaled carbon monoxide levels (CO). This presentation will focus on reporting the primary effectiveness outcome of the intervention, and initial qualitative process evaluation findings, before considering implications for practice.
Chair
Heidi Croucher Dorset Integrated Care System Treating Tobacco Dependency Programme Manager, Lead Implementation Midwife, NHS England - Public Health Dorset
Speaker
Prof Caitlin Notley Director – Lifespan Health Research Centre and Professor of Addiction Sciences - Norwich Medical School, University of East Anglia
Dr Pippa Belderson Senior Research Associate - University of East Anglia
« Back